Both in Pharmaceuticals
United Therapeutics vs Royalty Pharma
Over the past year UTHR returned +34.4% and RPRX returned +79.0%; their daily moves had a correlation of 0.21.
UTHR +34.4% RPRX +79.0%Growth of $1, one year, split-adjusted
| Metric | UTHR | RPRX |
|---|---|---|
| Price | $598.72 | $67.18 |
| Market cap | $25.68B | $29.91B |
| Today | +0.87% | +1.90% |
| 1 month | +4.8% | +16.6% |
| 6 months | +5.0% | +35.8% |
| Year to date | +22.9% | +73.9% |
| 1 year | +31.5% | +83.2% |
| Revenue growth (YoY) | −1.9% | +16.5% |
| Gross margin | 87.3% | 100.0% |
| Net margin | 42.5% | 2.7% |
| P/E (TTM) | 19.6× | 36.7× |
| Price / sales | 8.1× | 11.8× |
| Net cash | $2.66B | -$8.23B |
| Dividend yield | — | 1.40% |
| Volatility (60d) | 37.7% | 24.9% |
| Short % of float | 5.9% | 2.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).